HAE
HAE
NYSE · Health Care

Haemonetics Corp/Mass

$72.87
+0.09 (+0.12%)
As of Jun 24, 8:55 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.28B
Net Income
93.39M
Gross Margin
59.0%
Profit Margin
7.3%
Rev Growth
+4.5%
D/E Ratio
1.54
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.0% 59.0% 54.3% 54.3%
Operating Margin 11.7% 10.6% 11.5% 11.0%
Profit Margin 7.3% 6.9% 7.9% 6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.28B 1.23B 2.17B 1.94B
Gross Profit 755.36M 722.77M 1.18B 1.05B
Operating Income 150.43M 129.55M 248.79M 212.97M
Net Income 93.39M 80.42M 171.22M 125.72M
Gross Margin 59.0% 59.0% 54.3% 54.3%
Operating Margin 11.7% 10.6% 11.5% 11.0%
Profit Margin 7.3% 6.9% 7.9% 6.5%
Rev Growth +4.5% +4.5% +24.6% +5.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.02B 1.02B 666.77M 805.22M
Total Equity 664.10M 664.10M 1.73B 1.53B
D/E Ratio 1.54 1.54 0.39 0.53
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 192.65M 175.12M 302.84M 250.08M
Free Cash Flow 163.13M 182.49M